Tarkim Bitki Koruma Sanayi ve Ticaret AS

Tarkim's capital structure shows a debt-to-equity ratio of 0.32, indicating a relatively conservative leverage position compared to the industry median of 0.45. However, the company's liquidity is rated as medium, with a current ratio of 1.25 and only 4.6 million TRY in cash and equivalents, which is significantly lower than the industry median of 120 million TRY. The negative free cash flow of -959.97 million TRY and capital expenditure of -913.76 million TRY suggest that the company is investing heavily in its operations, but this is not being offset by positive cash generation. Profitability metrics are weak, with a return on equity of -3.58% and a return on assets of -2.5%, both well below the industry median of 8.2% and 6.1%, respectively. The company reported a net loss of 97.11 million TRY, despite a gross profit of 556.98 million TRY, indicating high operating expenses and potential inefficiencies in cost management. Tarkim's revenue is concentrated in a single business segment, as disclosed in its latest financial report, with no geographic diversification provided in the available data. This lack of diversification increases exposure to regional economic and regulatory risks. The company's growth trajectory is uncertain, with no specific revenue growth projections provided in the available data. However, the significant capital expenditure and negative free cash flow suggest that the company is investing in future growth, though the immediate financial impact is negative. Risk factors include medium liquidity risk due to low cash reserves and negative free cash flow, as well as a key flag indicating that net cash is negative after subtracting total debt. The dilution risk is rated as low, with no near-term pressure expected, and no recent events such as major filings or transcripts that would suggest a change in this assessment. Recent financial filings and transcripts do not indicate any major events that would significantly alter the company's risk profile or financial outlook. The company's operations remain focused on its core agricultural chemicals business, with no new product lines or strategic shifts disclosed in the available data.